Stereotaxis, Inc. revenue by segment STXS

Stereotaxis, Inc. splits its revenue into 3 lines in its filings. The largest line in fiscal 2025, which ended Dec 31, 2025 was Disposables Service And Accessories at $22.2 million, 68% of the total.

USD in millions. The percent under a figure is the change from the year before.

Line
FY 2026
Jun 30, 2026
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
FY 2019
Dec 31, 2019
FY 2018
Dec 31, 2018
FY 2017
Dec 31, 2017
FY 2016
Dec 31, 2016
Revenue
30
32
27
27
28
35
27
29
29
31
32
Disposables Service And Accessories
22
+4.9%
share 73.3%
22
+21.2%
share 68.4%
18
+1.4%
share 67.9%
18
-15.4%
share 67.4%
21
-6.8%
share 75.7%
23
+3.9%
share 65.3%
22
share 82.7%
—
—
—
—
Systems
8
-25.6%
share 26.7%
10
+18.4%
share 31.6%
9
-1.2%
share 32.1%
9
+27.7%
share 32.6%
7
-38.7%
share 24.3%
11
+208.0%
share 31.9%
4
share 13.6%
—
—
—
—
Sublease
—
—
—
—
—
1
+0.0%
share 2.8%
1
share 3.7%
—
—
—
—
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.

Company profile

Industry
Electromedical & Electrotherapeutic Apparatus (SIC 3845)
Listed as
STXS (NYSE)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
St.Louis, MO
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1289340

Other Electromedical & Electrotherapeutic Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.